Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
about
Reinventing HCV Treatment: Past and Future Perspectives.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionMedical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, CanadaMortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data.A Hepatitis C Treatment Program Based in a Safety-Net Hospital Patient-Centered Medical Home.Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department.Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease.Influence of camel milk on the hepatitis C virus burden of infected patients.Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.Viral evasion and challenges of hepatitis C virus vaccine development.Improving Hepatitis C Identification: Technology Alone Is Not the Answer.A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.Reducing branded prescription drug prices: A review of policy options.The National Academy Report on the Elimination of Viral Hepatitis: An Infectious Disease Physician's Perspective.State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs - United States, 2015-2016.Continuum of Care for Hepatitis C Virus Among Patients Diagnosed in the Emergency Department Setting.Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination.Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.Branded prescription drug spending: a framework to evaluate policy options.C-WORTHY: the beginning of the rise of elbasvir and grazoprevir for the treatment of hepatitis C genotype 1 mono and HIV co-infected patients.Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study.Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.The Order of Addition of Immunocompromise: The Effects of HIV Infection on Fibrosis Progression Among Hepatitis C Virus-Infected Patients.Mortality Waves Related to Hepatitis C Virus Infection: Multiple Causes of Death Data From the United States and Northern Italy Compared.Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers.Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.GHOST: global hepatitis outbreak and surveillance technology.Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus.The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus.Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population.Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.State HCV Incidence and Policies Related to HCV Preventive and Treatment Services For Persons Who Inject Drugs - United States, 2015-2016.Cigarette Smoking in Persons Living with Hepatitis C: the National Health and Nutrition Examination Survey (NHANES), 1999-2014.Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines.Results of a Hepatitis C Virus Screening Program of the 1945-1965 Birth Cohort in a Large Emergency Department in New Jersey.
P2860
Q30241881-79B5A362-BE42-4858-9EBE-2C4FEFE60AEEQ33707925-6B4842DD-6F10-4ACD-BEEA-6983358201EAQ33853664-43535B93-AFB5-4B47-9FBE-2220B69E7E1CQ36279118-6A39DFAA-FC5F-4225-862F-E30AE54C02CFQ36324700-11FDF01D-2C43-489C-A0E1-F5BC2083D693Q36366464-B80081FE-35C4-45C6-9253-1F927A6FE834Q36994022-FC8D4A06-5976-4A3B-B35A-8F186F535671Q37305565-540D9DF7-4D6A-4C56-B8CE-B85047239013Q37734598-D4D981E7-D824-4053-B4D1-E8C44F5846C8Q38635796-69CF54E9-95B7-4B7D-959D-F1686CCDE255Q38854076-1390929A-7B69-4EE0-9AEB-730C3C55605EQ38893244-5527E313-0F46-45D8-BD65-3F1439FCDCEFQ38961608-6FF8F2AA-7BB1-47D9-AC8B-AAA8192B82D2Q40047408-062531F8-922B-4922-86FD-10F06A1BE01CQ40075326-B7B34205-A6B1-4DB4-B84D-FABE1FA2E613Q40083993-89061A98-268B-4384-B30D-541BFFA64BDFQ40175562-7C1FFC32-D899-475A-8653-29D733A40893Q40205955-6758EECE-9D70-4C24-8FAE-BBE5F6B56C81Q40330235-B7316D3F-CBE3-4E69-86E0-0AF7B294843DQ40588090-94EE1F9B-DB56-4EA9-B35A-C6203749032AQ41689458-4509D1D8-E808-4277-A904-A2D3F8DFBF45Q42048758-B38BA2BD-3983-4D99-9B0C-DE676C722036Q42284328-4E57E25A-D88A-4FC0-B735-AB56036C5180Q42370370-C0FC0758-7DF2-4A2E-AC50-E2805ED3DA90Q44297171-371412E3-E86D-44C6-825D-C4F5D5F7FD08Q45324640-7295EBFC-9E34-48A6-989B-744E7B01A3E2Q45325465-36096531-8B5F-48D0-BFFF-C10F7B0CA143Q45334201-C381CEED-E950-43D3-AAFC-328B1CFC86AFQ45335172-E82266F4-2A51-4BC2-B9B5-3C45BDC824DFQ46257792-D494ABD7-E614-4F08-9158-EC15BA543F0FQ46288266-9609F3E2-C8C1-4470-A111-53867B75FA93Q47101713-A183EC12-9FC3-45CA-9D82-E64C127D928EQ47548062-DBE44872-BE6E-4E61-97AA-B4B564452A2DQ47549498-B5907146-40F6-4057-93DF-A02486CEB33AQ47564118-508FF09B-0F1C-4303-84D3-BCA50051F450Q47631237-781DB92F-94EE-4960-B1C9-191766F0452DQ47727043-954A8EA5-C58C-4457-B57E-BB687F4B107AQ50170882-61F51A27-7A43-42BB-AD9B-3E75E3641114Q52564579-44B11717-D07E-489E-92B4-C890D7940767Q52587031-2B4C5851-DEA4-4991-AAA7-E7B13FF099F3
P2860
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
@en
type
label
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
@en
prefLabel
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
@en
P2093
P2860
P356
P1476
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.
@en
P2093
Elizabeth M Hughes
Kathleen N Ly
Ruth B Jiles
Scott D Holmberg
P2860
P304
P356
10.1093/CID/CIW111
P407
P577
2016-03-01T00:00:00Z